Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
AIDS and Behavior
Erschienen in: AIDS and Behavior 5/2010

01.10.2010 | Original Paper

Factors Determining Prenatal HIV Testing for Prevention of Mother to Child Transmission of HIV in Mpumalanga, South Africa

verfasst von: Karl Peltzer, Gladys Mlambo, Khanyisa Phaweni

Erschienen in: AIDS and Behavior | Ausgabe 5/2010

Einloggen, um Zugang zu erhalten

Abstract

This study assessed factors associated with participation in HIV counseling and testing and reported reasons for not taking part in Voluntary HIV Counseling and Testing among 930 pregnant women attending clinics for antenatal care in South Africa. Results indicate that from 930 clients interviewed 87% had agreed to participate in individual pre-test HIV counseling and 81.2% had received their test results in post-test counseling. Fear for taking the test, lack of confidentiality and knowing one’s HIV status were the main reasons why women refused to test. In multivariable analysis trust of HCT provider was associated with participation in HIV pre-test counseling and no risky drinking was associated with participation in HIV post-test counseling. These findings suggest mistrust towards HCT providers should be reduced and screening and brief intervention for alcohol problems provided.
Literatur
1.
De Cock KM, Fowler MG, Mercier E, de Vincenzi I, Saba J. Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice. JAMA. 2000;283(9):1175–82.CrossRefPubMed
2.
Paintsil E, Andiman WA. Update on successes and challenges regarding mother-to-child transmission of HIV. Curr Opin Pediatr. 2009;21(1):94–101.CrossRefPubMed
3.
Sarker M, Sanou A, Snow R, Ganame J, Gondos A. Determinants of HIV counselling and testing participation in a prevention of mother-to-child transmission programme in rural Burkina Faso. Trop Med Int Health. 2007;12(12):1475–83.CrossRefPubMed
4.
WHO. Guidance on provider-initiated HIV testing and counselling in health facilities. Geneva: WHO; 2007.
5.
6.
Day C, Barron P, Monticelli F, Sello E. The district health barometer—year 2007/08. Durban: Health Systems Trust; 2009.
7.
Department of Health. The national HIV and syphilis prevalence survey in South Africa 2007. Pretoria: Department of Health; 2008.
8.
Dahl V, Mellhammar L, Bajunirwe F, Björkman P. Acceptance of HIV testing among women attending antenatal care in south-western Uganda: risk factors and reasons for test refusal. AIDS Care. 2008;20(6):746–52.CrossRefPubMed
9.
Mahmoud MM, Nasr AM, Gassmelseed DE, Abdalelhafiz MA, Elsheikh MA, Adam I. Knowledge and attitude toward HIV voluntary counseling and testing services among pregnant women attending an antenatal clinic in Sudan. J Med Virol. 2007;79(5):469–73.CrossRefPubMed
10.
Pignatelli S, Simpore J, Pietra V, et al. Factors predicting uptake of voluntary counselling and testing in a real-life setting in a mother-and-child center in Ouagadougou, Burkina Faso. Trop Med Int Health. 2006;11:350–7.CrossRefPubMed
11.
Bajunirwe F, Muzoora M. Barriers to the implementation of programs for the prevention of mother-to-child transmission of HIV: a cross-sectional survey in rural and urban Uganda. AIDS Res Ther. 2005;2:10–8.CrossRefPubMed
12.
Bakari JP, McKenna S, Myrick A, Mwinga K, Bhat GJ, Allen S. Rapid voluntary testing, counseling for HIV. Acceptability and feasibility in Zambian antenatal care clinics. Ann N Y Acad Sci. 2000;918:64–76.CrossRefPubMed
13.
Fabiani M, Cawthorne A, Nattabi B, Ayella EO, Ogwang M, Declich S. Investigating factors associated with uptake of HIV voluntary counselling and testing among pregnant women living in North Uganda. AIDS Care. 2007;19(6):733–9.CrossRefPubMed
14.
Holmes C, Preko P, Bolds R, Baidoo J, Jolly PE. Acceptance of voluntary counselling, testing and treatment for HIV among pregnant women in Kumasi, Ghana. Ghana Med J. 2008;42(1):8–15.PubMed
15.
Matovu JK, Gray RH, Makumbi F, et al. Voluntary HIV counseling and testing acceptance, sexual risk behavior and HIV incidence in Rakai, Uganda. AIDS. 2005;19(5):503–11.CrossRefPubMed
16.
Kebaabetswe PM. Barriers to participation in the prevention of mother-to-child HIV transmission program in Gaberone, Botswana: a qualitative approach. AIDS Care. 2007;19(3):355–60.CrossRefPubMed
17.
Minnie K, Klopper H, van der Walt C. Factors contributing to the decision by pregnant women to be tested for HIV. Health SA Gesondheid. 2008;13(4):50–65.
18.
Kominami M, Kawata K, Ali M, Meena H, Ushijima H. Factors determining prenatal HIV testing for prevention of mother to child transmission in Dar Es Salaam, Tanzania. Pediatr Int. 2007;49:286–92.CrossRefPubMed
19.
Maedot P, Haile A, Lulseged S, Belachew A. Determinants of VCT uptake among pregnant women attending two ANC clinics in Addis Ababa City: unmatched case control study. Ethiop Med J. 2007;45(4):335–42.PubMed
20.
Varga C, Brookes H. Factors influencing teen mothers’ enrollment and participation in prevention of mother-to-child HIV transmission services in Limpopo Province, South Africa. Qual Health Res. 2008;18(6):786–802.CrossRefPubMed
21.
Painter TM, Diaby KL, Matia DM, et al. Sociodemographic factors associated with participation by HIV-1-positive pregnant women in an intervention to prevent mother-to-child transmission of HIV in Cote d’Ivoire. Int J STD AIDS. 2005;16(3):237–42.CrossRefPubMed
22.
Chopra M, Doherty T, Jackson D, Ashworth A. Preventing HIV transmission to children: quality of counselling of mothers in South Africa. Acta Paediatr. 2005;94:357–63.CrossRefPubMed
23.
Delva W, Mutunga L, Quaghebeur A, Temmerman M. Quality and quantity of antenatal HIV counselling in a PMTCT programme in Mombasa, Kenya. AIDS Care. 2006;18(3):189–93.CrossRefPubMed
24.
Mfundisi C, Chiranjan N, Rodrigues C, Kirchner L, Bock P, Myer L. Availability of antiretroviral therapy is associated with increased uptake of HIV testing services. S Afr Med J. 2005;95(7):483–5.PubMed
25.
De Paoli MM, Manongi R, Klepp KI. Factors influencing acceptability of voluntary counselling and HIV-testing among pregnant women in Northern Tanzania. AIDS Care. 2004;16(4):411–25.CrossRefPubMed
26.
Miller KS, Hennessy M, Wendell DA, Webber MP, Schoenbaum EE. Behavioral risks for HIV infection associated with HIV-testing decisions. AIDS Educ Prev. 1996;8(5):394–402.PubMed
27.
Mpairwe H, Muhangi L, Namujju PB, et al. HIV risk perception and prevalence in a program for prevention of mother-to-child HIV transmission: comparison of women who accept voluntary counseling and testing and those tested anonymously. J Acquir Immune Defic Syndr. 2005;39(3):354–8.CrossRefPubMed
28.
Martin-Herz SP, Shetty AK, Bassett MT, et al. Perceived risks and benefits of HIV testing, and predictors of acceptance of HIV counselling and testing among pregnant women in Zimbabwe. Int J STD AIDS. 2006;17(12):835–41.CrossRefPubMed
29.
Department of Health and Social Services, Mpumalanga. PMTCT report. Nelspruit: Author; 2008.
30.
Nguyen A, Oosterhoff P, Ngoc YP, Wright P, Hardon A. Barriers to access prevention of mother-to-child transmission for HIV positive women in a well-resourced setting in Vietnam. AIDS Res Ther. 2008;5:7.CrossRefPubMed
31.
Boshamer CB, Bruce KE. A scale to measure attitudes about HIV-antibody testing: development and psychometric validation. AIDS Educ Prev. 1999;11:400–13.PubMed
32.
Wu E, El-Bassel N, Witte SS, Gilbert L, Chang M. Intimate partner violence and HIV risk among urban minority women in primary health care settings. AIDS Behav. 2003;7(3):291–301.CrossRefPubMed
33.
Babor TF, Higgens-Biddle JC, Saunders JB, Monteiro MG. AUDIT: the alcohol use disorders identification test. Guidelines for use in primary care. Geneva: Department of Mental Health and Substance Dependence. World Health Organization, WHO/MSD/MSB/01.6a.; 2001.
34.
Freeborn DK, Polen RP, Hollis JF, Senft RA. Screening and brief intervention for hazardous drinking in an HMO: effects on medical care utilization. J Behav Health Serv Res. 2000;27:446–53.CrossRefPubMed
35.
Kleinbaum DG. Epidemiologic methods: the ‘art’ in the state of the art. J Clin Epidemiol. 2002;55:1196–200.CrossRefPubMed
36.
Centers for Disease Control and Prevention (CDC). Introduction of routine HIV testing in prenatal care—Botswana, 2004. Morb Mortal Wkly Rept. 2004;53(46):1083–6.
37.
Kalichman SC, Simbayi LC. HIV testing attitudes, AIDS stigma, and voluntary HIV counseling and testing in a Black township in Cape Town, South Africa. Sex Transm Infect. 2003;79:442–7.CrossRefPubMed
38.
WHO. Guidance on global scale-up of the prevention of mother-to-child transmission of HIV towards universal access for women, infants and young children and eliminating HIV and AIDS among children. Geneva: WHO; 2007.
39.
Anand A, Shiraishi RW, Sheikh AA et al. Site factors may be more important than participant factors in explaining HIV test acceptance in the prevention of mother-to-child HIV transmission programme in Kenya, 2005. Trop Med Int Health. 2009;14(10):1215–9.CrossRefPubMed
Metadaten
Titel
Factors Determining Prenatal HIV Testing for Prevention of Mother to Child Transmission of HIV in Mpumalanga, South Africa
verfasst von
Karl Peltzer
Gladys Mlambo
Khanyisa Phaweni
Publikationsdatum
01.10.2010
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 5/2010
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-009-9662-7

Weitere Artikel der Ausgabe 5/2010

AIDS and Behavior 5/2010 Zur Ausgabe

Original Paper

Social-Level Correlates of Shooting Gallery Attendance: A Focus on Networks and Norms

Original Paper

Factors Associated with Condom Use Among HIV Clients in Stable Relationships with Partners at Varying Risk for HIV in Uganda

Original Paper

Social Norms, Social Networks, and HIV Risk Behavior Among Injection Drug Users

Brief Report

Male Circumcision and HIV Prevention: Looking to the Future

Original Paper

Prevalence of Child and Adult Sexual Abuse and Risk Taking Practices Among HIV Serodiscordant African-American Couples

Original Paper

Knowledge and Attitudes About Male Circumcision for HIV-1 Prevention among Heterosexual HIV-1 Serodiscordant Partnerships in Kampala, Uganda

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise